NCT04874051 (BALANCE) is a NA clinical trial of Experimental Group in Stroke, sponsored by IRCCS San Camillo, Venezia, Italy.

Who is sponsoring NCT04874051?

NCT04874051 is sponsored by IRCCS San Camillo, Venezia, Italy.

What drugs are being tested in NCT04874051?

Interventions in NCT04874051: Experimental Group, Control Group.

What condition does NCT04874051 study?

NCT04874051 studies Stroke, Multiple Sclerosis, Parkinson Disease.

Is NCT04874051 still recruiting?

NCT04874051 is currently status unknown. Last updated 22 March 2023.

Last reviewed 2023-03-22 · How we verify

NCT04874051: BALANCE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sensor-based Assessment and Rehabilitation of Balance in Neurological Diseases

Status unknown NA Last updated 22 March 2023

What this trial tests

NA trial testing Experimental Group in Stroke in 120 participants. Status unknown.

Timeline

2 September 2019

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	IRCCS San Camillo, Venezia, Italy
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	120
Start date	2 September 2019
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	5 locations across Italy

Drugs / interventions tested

Experimental Group
Control Group — full drug profile →

Conditions studied

Stroke — all drugs for Stroke →
Multiple Sclerosis — all drugs for Multiple Sclerosis →
Parkinson Disease — all drugs for Parkinson Disease →

Sponsor

IRCCS San Camillo, Venezia, Italy

Who can join

Adults 18 to 90, any sex, with Stroke or Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Balance impairment is one of the most common disorders due to a neurological diseases. Sensor-based technologies may be useful for falls prevention and balance recovery during patients hospitalization. OAK Elderly Care System (Khymeia Group, Noventa Padovana, Italy) allows the assessment of fall risk, the centre of pressure and the execution of balance exercises in a virtual environment.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Interventions for preventing falls in Parkinson's disease.
Allen NE, Canning CG, Almeida LRS, Bloem BR, et al · · 2022 · cited 50× · PMID 35665915 · DOI 10.1002/14651858.cd011574.pub2

Verify or expand the search:

Other trials of Experimental Group

Trials testing the same drug.

NCT07511894 — Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric Cancer · Phase 2 · not yet recruiting
NCT07505472 — Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit · Phase 2, PHASE3 · recruiting
NCT07316946 — Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial · NA · not yet recruiting
NCT07125820 — A Dual Intervention in Migraine Treatment: Tens and Exercise · NA · not yet recruiting
NCT07514637 — Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.I · Phase 2 · recruiting

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other IRCCS San Camillo, Venezia, Italy trials

Trials by the same sponsor.

NCT05956132 — Clinical and Biochemical Features for the Identification of Dominant Calpainopathies · unknown
NCT05934188 — Exploring the Gut-Brain Axis in Ageing and Neurodegeneration · recruiting
NCT06264037 — The Experience in Neurorehabilitation Setting: a Qualitative Study · unknown
NCT06270420 — Technological Devices and Home Automation System in Neurological Rehabilitation · NA · unknown
NCT05591040 — Biofeedback as an Adjunctive Treatment for Post-stroke Dysphagia · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04874051 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by IRCCS San Camillo, Venezia, Italy
Last refreshed: 22 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04874051.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing